Clinical trials
Withdrawn Phase 2 Neuroblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Cancer and Leukaemia Group | 1 |
| Children's Oncology Group | 1 |
| Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 1 |
| Molecular Insight Pharmaceuticals, Inc. | 1 |
| NYU Langone Health | 1 |
| Nationwide Children's Hospital | 1 |
| Sue O'Dorisio | 1 |
| University of California, San Francisco | 1 |
| University of Iowa | 1 |
| Y-mAbs Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 10 |
| Central Nervous System Neoplasms | 1 |
| Choroid Plexus Neoplasms | 1 |
| Hepatoblastoma | 1 |
| Medulloblastoma | 1 |
| Meningioma | 1 |
| Neuroectodermal Tumors, Primitive, Peripheral | 1 |
| Neuroendocrine Tumors | 1 |
| Osteosarcoma | 1 |
| Paraganglioma | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.